BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21812053)

  • 1. The PINIT domain of PIAS3: structure-function analysis of its interaction with STAT3.
    Mautsa N; Prinsloo E; Bishop ÖT; Blatch GL
    J Mol Recognit; 2011; 24(5):795-803. PubMed ID: 21812053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor cell death.
    Borghouts C; Tittmann H; Delis N; Kirchenbauer M; Brill B; Groner B
    Mol Cancer Res; 2010 Apr; 8(4):539-53. PubMed ID: 20371673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM8 modulates STAT3 activity through negative regulation of PIAS3.
    Okumura F; Matsunaga Y; Katayama Y; Nakayama KI; Hatakeyama S
    J Cell Sci; 2010 Jul; 123(Pt 13):2238-45. PubMed ID: 20516148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The enigma of the role of protein inhibitor of activated STAT3 (PIAS3) in the immune response.
    Yagil Z; Nechushtan H; Kay G; Yang CM; Kemeny DM; Razin E
    Trends Immunol; 2010 May; 31(5):199-204. PubMed ID: 20181527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific epitope of protein inhibitor of activated STAT3 is responsible for the induction of apoptosis in rat transformed mast cells.
    Yagil Z; Kay G; Nechushtan H; Razin E
    J Immunol; 2009 Feb; 182(4):2168-75. PubMed ID: 19201870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of STAT3 activity by Duplin, which is a negative regulator of the Wnt signal.
    Yamashina K; Yamamoto H; Chayama K; Nakajima K; Kikuchi A
    J Biochem; 2006 Feb; 139(2):305-14. PubMed ID: 16452319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein inhibitor of activated STAT3 inhibits adipogenic gene expression.
    Deng J; Hua K; Caveney EJ; Takahashi N; Harp JB
    Biochem Biophys Res Commun; 2006 Jan; 339(3):923-31. PubMed ID: 16329991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperative interaction between protein inhibitor of activated signal transducer and activator of transcription-3 with epidermal growth factor receptor blockade in lung cancer.
    Kluge A; Dabir S; Kern J; Nethery D; Halmos B; Ma P; Dowlati A
    Int J Cancer; 2009 Oct; 125(7):1728-34. PubMed ID: 19569236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear Smad6 promotes gliomagenesis by negatively regulating PIAS3-mediated STAT3 inhibition.
    Jiao J; Zhang R; Li Z; Yin Y; Fang X; Ding X; Cai Y; Yang S; Mu H; Zong D; Chen Y; Zhang Y; Zou J; Shao J; Huang Z
    Nat Commun; 2018 Jun; 9(1):2504. PubMed ID: 29950561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The zinc finger protein Gfi-1 can enhance STAT3 signaling by interacting with the STAT3 inhibitor PIAS3.
    Rödel B; Tavassoli K; Karsunky H; Schmidt T; Bachmann M; Schaper F; Heinrich P; Shuai K; Elsässer HP; Möröy T
    EMBO J; 2000 Nov; 19(21):5845-55. PubMed ID: 11060035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of ATBF1 activates STAT3 signaling via PIAS3 in pacing-induced HL-1 atrial myocytes.
    Jiang Q; Ni B; Shi J; Han Z; Qi R; Xu W; Wang D; Wang DW; Chen M
    Biochem Biophys Res Commun; 2014 Jul; 449(3):278-83. PubMed ID: 24857987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low PIAS3 expression in malignant mesothelioma is associated with increased STAT3 activation and poor patient survival.
    Dabir S; Kluge A; Kresak A; Yang M; Fu P; Groner B; Wildey G; Dowlati A
    Clin Cancer Res; 2014 Oct; 20(19):5124-32. PubMed ID: 25124686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel non-phosphorylated potential antitumoral peptide inhibits STAT3 biological activity.
    Dourlat J; Liu WQ; Sancier F; Edmonds T; Pamonsinlapatham P; Cruzalegui F; Garbay C
    Biochimie; 2009 Aug; 91(8):996-1002. PubMed ID: 19470402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of STAT3-independent regulatory effects for protein inhibitor of activated STAT3 by binding to novel transcription factors.
    Dabir S; Kluge A; Aziz MA; Houghton JA; Dowlati A
    Cancer Biol Ther; 2011 Jul; 12(2):139-51. PubMed ID: 21532337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the binding determinants of phosphopeptides targeted to the SRC homology 2 domain of the signal transducer and activator of transcription 3. Development of a high-affinity peptide inhibitor.
    Coleman DR; Ren Z; Mandal PK; Cameron AG; Dyer GA; Muranjan S; Campbell M; Chen X; McMurray JS
    J Med Chem; 2005 Oct; 48(21):6661-70. PubMed ID: 16220982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association and nuclear translocation of the PIAS3-STAT3 complex is ligand and time dependent.
    Dabir S; Kluge A; Dowlati A
    Mol Cancer Res; 2009 Nov; 7(11):1854-60. PubMed ID: 19903771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Inhibitor of Activated STAT3 (PIAS3) Is Down-Regulated in Eutopic Endometrium of Women with Endometriosis.
    Yoo JY; Jeong JW; Fazleabas AT; Tayade C; Young SL; Lessey BA
    Biol Reprod; 2016 Jul; 95(1):11. PubMed ID: 27226311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein inhibitor of activated STAT3 reduces peripheral arthritis and gut inflammation and regulates the Th17/Treg cell imbalance via STAT3 signaling in a mouse model of spondyloarthritis.
    Min HK; Choi J; Lee SY; Seo HB; Jung K; Na HS; Ryu JG; Kwok SK; Cho ML; Park SH
    J Transl Med; 2019 Jan; 17(1):18. PubMed ID: 30630513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SHP2, SOCS3 and PIAS3 Expression Patterns in Medulloblastomas: Relevance to STAT3 Activation and Resveratrol-Suppressed STAT3 Signaling.
    Li C; Li H; Zhang P; Yu LJ; Huang TM; Song X; Kong QY; Dong JL; Li PN; Liu J
    Nutrients; 2016 Dec; 9(1):. PubMed ID: 28035977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. YB1 protects cardiac myocytes against H2O2‑induced injury via suppression of PIAS3 mRNA and phosphorylation of STAT3.
    Wang S; He F; Li Z; Hu Y; Huangfu N; Chen X
    Mol Med Rep; 2019 Jun; 19(6):4579-4588. PubMed ID: 30942400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.